FLT3 and acute lymphoblastic leukemia: Previously published work demonstrated that some ALL samples did have high FLT3 expression and that ALL lymphoblasts in culture were sensitive to FLT3 inhibitors, but no clinical trial results of ALL patients had been reported using these drugs (Armstrong et al. 2002; Brown et al. 2005).